Lifevantage Stock Performance
| LFVN Stock | USD 5.30 0.16 2.93% |
The company secures a Beta (Market Risk) of 1.13, which conveys a somewhat significant risk relative to the market. Lifevantage returns are very sensitive to returns on the market. As the market goes up or down, Lifevantage is expected to follow. At this point, Lifevantage has a negative expected return of -0.41%. Please make sure to verify Lifevantage's maximum drawdown, as well as the relationship between the accumulation distribution and price action indicator , to decide if Lifevantage performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Lifevantage has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2026. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Actual Historical Performance (%)
One Day Return (2.93) | Five Day Return (11.22) | Year To Date Return (12.11) | Ten Year Return (36.37) | All Time Return (82.33) |
Forward Dividend Yield 0.0331 | Payout Ratio | Last Split Factor 1:7 | Forward Dividend Rate 0.18 | Dividend Date 2025-12-15 |
1 | Are Investors Undervaluing Lifevantage Right Now | 11/10/2025 |
2 | Lacklustre Performance Is Driving LifeVantage Corporations 28 percent Price Drop | 11/14/2025 |
3 | Reviewing Lifevantage Vapor | 11/21/2025 |
4 | Should Value Investors Buy Lifevantage Stock | 11/26/2025 |
5 | LifeVantage Announces Resignation of Two Key Executives - TipRanks | 12/09/2025 |
| Lifevantage dividend paid on 15th of December 2025 | 12/15/2025 |
6 | Disposition of 601 shares by Todd Thompson of Lifevantage at 6.23 subject to Rule 16b-3 | 12/23/2025 |
7 | Is Lifevantage a Great Value Stock Right Now | 12/30/2025 |
8 | LifeVantage to Participate in the 28th Annual ICR Conference | 01/06/2026 |
9 | LifeVantage to Announce Second Quarter Fiscal Year 2026 Results on February 4, 2026 | 01/21/2026 |
| Begin Period Cash Flow | 16.9 M | |
| Total Cashflows From Investing Activities | -1.4 M |
Lifevantage | Build AI portfolio with Lifevantage Stock |
Lifevantage Relative Risk vs. Return Landscape
If you would invest 729.00 in Lifevantage on November 1, 2025 and sell it today you would lose (183.00) from holding Lifevantage or give up 25.1% of portfolio value over 90 days. Lifevantage is currently does not generate positive expected returns and assumes 3.6134% risk (volatility on return distribution) over the 90 days horizon. In different words, 32% of stocks are less volatile than Lifevantage, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Lifevantage Target Price Odds to finish over Current Price
The tendency of Lifevantage Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 5.30 | 90 days | 5.30 | about 97.0 |
Based on a normal probability distribution, the odds of Lifevantage to move above the current price in 90 days from now is about 97.0 (This Lifevantage probability density function shows the probability of Lifevantage Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.13 . This indicates Lifevantage market returns are highly reactive to returns on the market. As the market goes up or down, Lifevantage is expected to follow. Additionally Lifevantage has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Lifevantage Price Density |
| Price |
Predictive Modules for Lifevantage
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Lifevantage. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lifevantage's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lifevantage Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Lifevantage is not an exception. The market had few large corrections towards the Lifevantage's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Lifevantage, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Lifevantage within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.69 | |
β | Beta against Dow Jones | 1.13 | |
σ | Overall volatility | 0.66 | |
Ir | Information ratio | -0.18 |
Lifevantage Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Lifevantage for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Lifevantage can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Lifevantage generated a negative expected return over the last 90 days | |
| Lifevantage has high historical volatility and very poor performance | |
| About 65.0% of the company shares are owned by institutional investors | |
| On 15th of December 2025 Lifevantage paid $ 0.045 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: LifeVantage to Announce Second Quarter Fiscal Year 2026 Results on February 4, 2026 |
Lifevantage Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Lifevantage Stock often depends not only on the future outlook of the current and potential Lifevantage's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lifevantage's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 13 M | |
| Cash And Short Term Investments | 20.2 M |
Lifevantage Fundamentals Growth
Lifevantage Stock prices reflect investors' perceptions of the future prospects and financial health of Lifevantage, and Lifevantage fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Lifevantage Stock performance.
| Return On Equity | 0.33 | ||||
| Return On Asset | 0.12 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 67.07 M | ||||
| Shares Outstanding | 12.7 M | ||||
| Price To Earning | 4.65 X | ||||
| Price To Book | 2.08 X | ||||
| Price To Sales | 0.30 X | ||||
| Revenue | 228.53 M | ||||
| Gross Profit | 183.76 M | ||||
| EBITDA | 15.36 M | ||||
| Net Income | 9.8 M | ||||
| Cash And Equivalents | 20.19 M | ||||
| Cash Per Share | 1.61 X | ||||
| Total Debt | 11.68 M | ||||
| Debt To Equity | 0.50 % | ||||
| Current Ratio | 1.83 X | ||||
| Book Value Per Share | 2.61 X | ||||
| Cash Flow From Operations | 11.88 M | ||||
| Earnings Per Share | 0.78 X | ||||
| Market Capitalization | 69.35 M | ||||
| Total Asset | 71.96 M | ||||
| Retained Earnings | (104.15 M) | ||||
| Working Capital | 23.68 M | ||||
| Current Asset | 42.41 M | ||||
| Current Liabilities | 28.55 M | ||||
About Lifevantage Performance
By examining Lifevantage's fundamental ratios, stakeholders can obtain critical insights into Lifevantage's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Lifevantage is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 151.34 | 113.58 | |
| Return On Tangible Assets | (0.32) | (0.34) | |
| Return On Capital Employed | (0.52) | (0.55) | |
| Return On Assets | (0.32) | (0.34) | |
| Return On Equity | (0.52) | (0.50) |
Things to note about Lifevantage performance evaluation
Checking the ongoing alerts about Lifevantage for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Lifevantage help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Lifevantage generated a negative expected return over the last 90 days | |
| Lifevantage has high historical volatility and very poor performance | |
| About 65.0% of the company shares are owned by institutional investors | |
| On 15th of December 2025 Lifevantage paid $ 0.045 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: LifeVantage to Announce Second Quarter Fiscal Year 2026 Results on February 4, 2026 |
- Analyzing Lifevantage's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Lifevantage's stock is overvalued or undervalued compared to its peers.
- Examining Lifevantage's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Lifevantage's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Lifevantage's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Lifevantage's stock. These opinions can provide insight into Lifevantage's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lifevantage. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. To learn how to invest in Lifevantage Stock, please use our How to Invest in Lifevantage guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Will Personal Care Products sector continue expanding? Could Lifevantage diversify its offerings? Factors like these will boost the valuation of Lifevantage. Expected growth trajectory for Lifevantage significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Lifevantage data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.214 | Dividend Share 0.17 | Earnings Share 0.78 | Revenue Per Share | Quarterly Revenue Growth 0.007 |
Understanding Lifevantage requires distinguishing between market price and book value, where the latter reflects Lifevantage's accounting equity. The concept of intrinsic value—what Lifevantage's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Lifevantage's price substantially above or below its fundamental value.
Understanding that Lifevantage's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Lifevantage represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Lifevantage's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.